The environment and cardiovascular disease
Rozenberg, S.
Arquivos Brasileiros de Cardiologia 37(5): 403-407
1981
ISSN/ISBN: 0066-782X PMID: 7347191 Document Number: 172033
Document emailed within 1 workday
Related Documents
Kristiansen, B.E.; Tveten, Y.; Ask, E.; Knapskog, A.B.; Reiten, T.; Steen-Johnsen, J.; Hopen, G. 1989: Examination of the environment in meningococcal disease. Identification and clearing of the virulent microorganism from the environment of patients with meningococcal disease Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(13): 1373-1376Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Santos, P.E.áq.d.B.; Bonamino, M.H.án. 2003: Cardiovascular effects of the exposure to a microgravitational environment Arquivos Brasileiros de Cardiologia 80(1): 105-115
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Thorogood, M. 1993: Anticonceptivos orales y enfermedad cardiovascular - Oral contraceptives and cardiovascular disease Beneficios y Riesgos de la Anticoncepcion Oral. Simposio (Caracas 1992-11) 9: 19-29
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Burkman, R.T. 1994: Noncontraceptive effects of hormonal contraceptives: Bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1569-1575
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Sanz, M.; D'Aiuto, F.; Deanfield, J.; Fernandez-Aviles, F. 2010: European workshop in periodontal health and cardiovascular disease--scientific evidence on the association between periodontal and cardiovascular diseases: a review of the literature European Heart Journal Suppls 12(Suppl B): B3-B12
Abrams, S.G.; Levitsky, S.; Monley, C.; Roth, R.; Perez, M. 1978: Automation in practice: analysis of cardiovascular function and cardiac patient data base management in a time-shared minicomputer environment Clinical Engineering 6(5): 59-62
Leone, O.; Agozzino, L.; Angelini, A.; Bartoloni, G.; Basso, C.; Caruso, G.; D'Amati, G.; Pucci, A.; Thiene, G.; Gallo, P. 2012: Criteria for histopathologic diagnosis of aortic disease consensus statement from the SIAPEC-IAP study group of "cardiovascular pathology" in collaboration with the association for Italian cardiovascular pathology Pathologica 104(1): 1-33
Sdiri, W.; Romdhane, H.; Mbarek, D.; Ben Abdallah, H.; Longo, S.; Abdelli, M.N.; Boujnah, M.R. 2013: Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease? La Tunisie Medicale 91(3): 171-174
DeRossi, S.S.; Sollecito, T.P. 2012: The oral-medical disease connection: pregnancy, cardiovascular disease, and diabetes Compendium of Continuing Education in Dentistry 33(6): 406
Zhang, X.; Hou, F.-f. 2010: Calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease Zhonghua Nei Ke Za Zhi 49(7): 555-557
Ishii, H.; Murohara, T. 2011: Interventional revascularization for cardiovascular disease in patients with chronic kidney disease Nihon Rinsho. Japanese Journal of Clinical Medicine 69(2): 339-342
Mahajan, A.; Qiu, J.; Stark, P.C.; Persson, R.; Kwack, C.; Levey, A.S.; Stevens, L.A. 2009: Prevalence of ICD-9-CM codes for chronic kidney disease in individuals with cardiovascular disease risk factors Journal of Nephrology 22(4): 523-533
Lapidus, L.; Lindstedt, G.; Lundberg, P.A.; Bengtsson, C.; Gredmark, T. 1986: Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women Clinical Chemistry 32(1 Part 1): 146-152
Quoc Hoang, T.A.; Tam, V.; Thang, H.V. 2019: Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease Medical Journal of Malaysia 74(3): 209-214